Image

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

Recruiting
21 years and older
All
Phase N/A

Powered by AI

Overview

This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.

Description

PRIMARY OBJECTIVE:

I. To formulate consensus agreement on a minimum set of clinical key elements that should be included in standardized reports in electronic health records when managing patients with prostate cancer.

OUTLINE

Participants complete 3-4 rounds of questionnaires over 20-30 minutes each over 2 weeks.

Eligibility

Inclusion Criteria:

  • Age 21 and above
  • Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
  • Maintenance of an active practice that includes prostate cancer patients
  • English speaking

Exclusion Criteria:

  • Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer
  • Prisoners, children, and adults unable to consent to participation will also be excluded
  • No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status

Study details
    Hematopoietic and Lymphoid Cell Neoplasm
    Malignant Solid Neoplasm

NCT05054413

M.D. Anderson Cancer Center

2 June 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.